Douglas Dieterich

Douglas Dieterich

UNVERIFIED PROFILE

Are you Douglas Dieterich?   Register this Author

Register author
Douglas Dieterich

Douglas Dieterich

Publications by authors named "Douglas Dieterich"

Are you Douglas Dieterich?   Register this Author

99Publications

2126Reads

38Profile Views

Reducing mother-to-child transmission of HCV: Is it attainable with a multidisciplinary approach?

J Hepatol 2019 Jul 24;71(1):229-230. Epub 2019 Apr 24.

Icahn School of Medicine, Mount Sinai Hospital, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.01.032DOI Listing
July 2019

Cost-effectiveness of pan-genotypic direct-acting antiviral regimens for treatment of chronic Hepatitis C in the United States.

Expert Rev Pharmacoecon Outcomes Res 2019 Jun 17:1-7. Epub 2019 Jun 17.

d Icahn School of Medicine at the Mount Sinai School of Medicine , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2019.1629291DOI Listing
June 2019

Liver Disease in Human Immunodeficiency Virus Infection.

Clin Liver Dis 2019 05 5;23(2):309-329. Epub 2019 Mar 5.

Icahn School of Medicine at Mount Sinai, 1 Gustav L. Levy Place, New York, NY 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2018.12.011DOI Listing
May 2019

Family Counseling for Hepatitis B and Hepatitis C.

Clin Liver Dis (Hoboken) 2019 Apr 30;13(4):93-97. Epub 2019 Apr 30.

Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cld.754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491030PMC
April 2019

Direct-acting antiviral treatment of acute hepatitis C virus infections.

Expert Rev Anti Infect Ther 2018 08 1;16(8):599-610. Epub 2018 Aug 1.

a Division of Liver Diseases, Department of Medicine , Icahn School of Medicine at Mount Sinai , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14787210.2018.1505502DOI Listing
August 2018

Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.

Int J Psychiatry Med 2018 07 3;53(4):256-272. Epub 2018 Jan 3.

6 Franklin Behavioral Health Consultants and Critica LLC, Bronx, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091217417749796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975203PMC
July 2018

Direct-acting antiviral treatment for patients with hepatocellular carcinoma.

Curr Opin Gastroenterol 2018 05;34(3):132-139

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0000000000000431DOI Listing
May 2018

Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.

Clin Liver Dis 2018 02 6;22(1):213-227. Epub 2017 Oct 6.

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, 17 East 102nd Street, 2nd Floor, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2017.08.015DOI Listing
February 2018

American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.

Gastroenterology 2017 05;152(6):1544-1577

Division of Gastroenterology and Hepatology, Cleveland VA Medical Center and University Hospitals, Case Western Reserve University, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.03.016DOI Listing
May 2017

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.

World J Hepatol 2017 Apr;9(11):551-561

Kian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, Neal M Patel, David Sachs, Michel Ng, Emily A Schonfeld, Alexis Pappas, James Crismale, Alicia Stivala, Viktoriya Khaitova, Donald Gardenier, Michael Linderman, William Olson, Ponni V Perumalswami, Thomas D Schiano, Joseph A Odin, Lawrence U Liu, Douglas T Dieterich, Andrea D Branch, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Icahn Medical Instititute, New York, NY 10029, United States.

View Article

Download full-text PDF

Source
http://www.wjgnet.com/1948-5182/full/v9/i11/551.htm
Publisher Site
http://dx.doi.org/10.4254/wjh.v9.i11.551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395804PMC
April 2017

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma.

J Investig Med High Impact Case Rep 2017 Apr-Jun;5(2):2324709617696854. Epub 2017 Apr 26.

Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2324709617696854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510768PMC
April 2017

Sofosbuvir in the treatment of early HCV infection in HIV-infected men.

HIV Clin Trials 2017 03 10;18(2):60-66. Epub 2017 Feb 10.

a Division of Infectious Diseases, Department of Medicine , Icahn School of Medicine at Mount Sinai , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15284336.2017.1280594DOI Listing
March 2017

Treating Medicaid patients with hepatitis C: clinical and economic impact.

Am J Manag Care 2017 Feb;23(2):107-112

Beatty Center for Integrated Research, 3300 Gallows Rd, Falls Church, VA 22042. E-mail:

View Article

Download full-text PDF

Source
February 2017

Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening.

Expert Rev Anti Infect Ther 2016 ;14(5):511-21

a Division of Liver Diseases, Icahn School of Medicine at Mount Sinai , NY , New York , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14787210.2016.1174066DOI Listing
December 2016

Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study.

Hepatology 2016 12 5;64(6):1893-1899. Epub 2016 Oct 5.

Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28782DOI Listing
December 2016

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care.

Medicine (Baltimore) 2016 Oct;95(41):e5048

aCenter For Liver Disease, Department of Medicine, Inova Fairfax Hospital bBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA cUniversity of Florida, Gainesville, FL dMount Sinai Medical Center, New York, NY eUniversity of California, Los Angeles, Los Angeles fStanford University, Standford, CA gHenry Ford Hospital, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072943PMC
October 2016

The use of generics to treat chronic hepatitis C: not quite ready for the big stage.

Liver Int 2016 07;36(7):933-5

Division of Liver Diseases, Deparment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13155DOI Listing
July 2016

About This Continuing Medical Education Activity.

Clin Infect Dis 2016 07;63 Suppl 1:S1-2

Division of Liver Disease, Department of Medicine, Icahn School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw218DOI Listing
July 2016

Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.

Clin Infect Dis 2016 07;63 Suppl 1:S3-S11

Division of Liver Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928450PMC
July 2016

Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C.

Am J Manag Care 2016 May;22(6 Spec No.):SP205-11

Beatty Center for Integrated Research, 3300 Gallows Road, Falls Church, VA 22042. E-mail:

View Article

Download full-text PDF

Source
May 2016

Directly acting antivirals for hepatitis C virus arrive in HIV/hepatitis C virus co-infected patients: from 'mind the gap' to 'where's the gap?'.

AIDS 2016 Apr;30(7):975-89

aInstitute of Liver StudiesbDepartment of Sexual Health, King's College Hospital, London, UKcDivision of Liver Disease, Icahn School of Medicine, Mount Sinai Medical Centre New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001042DOI Listing
April 2016

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus.

World J Gastroenterol 2016 Mar;22(9):2844-54

Neal Patel, Kian Bichoupan, Lawrence Ku, Rachana Yalamanchili, Alyson Harty, Donald Gardenier, Michel Ng, David Motamed, Viktoriya Khaitova, Nancy Bach, Charissa Chang, Priya Grewal, Meena Bansal, Ritu Agarwal, Lawrence Liu, Gene Im, Jennifer Leong, Leona Kim-Schluger, Joseph Odin, Jawad Ahmad, Scott Friedman, Douglas Dieterich, Thomas Schiano, Ponni Perumalswami, Andrea Branch, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i9.2844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778007PMC
March 2016

HCV vertical transmission in pregnancy: New horizons in the era of DAAs.

Hepatology 2015 Dec 21;62(6):1656-8. Epub 2015 Oct 21.

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28032DOI Listing
December 2015

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.

Clin Gastroenterol Hepatol 2015 Nov 15;13(12):2071-87.e16. Epub 2015 Jul 15.

Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565150096
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2015.07.007DOI Listing
November 2015

Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs.

World J Gastroenterol 2015 Nov;21(43):12430-8

Joshua Hartman, Department of Medicine, Icahn School of Medicine at the Mount Sinai Medical Center, New York, NY 10029, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i43.12430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649126PMC
November 2015

Current Issues Involving Screening for Hepatitis C Virus Infection.

Gastroenterol Hepatol (N Y) 2015 Nov;11(11):778-80

Director of the Institute of Liver Medicine Professor of Medicine Division of Liver Diseases Mount Sinai School of Medicine New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849506PMC
November 2015

Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A Concern.

Health Aff (Millwood) 2015 Oct;34(10):1666-74

Dana P. Goldman is the Leonard D. Schaeffer Chair and director of the Schaeffer Center for Health Policy and Economics at the University of Southern California, in Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.1193DOI Listing
October 2015

Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.

Curr Opin HIV AIDS 2015 Sep;10(5):337-47

aInfectious Diseases Department, Mount Sinai Hospital, New York City, New York, USA bInfectious Diseases Department, University Hospital, Dijon, France cLiver Department, Mount Sinai Hospital, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0000000000000182DOI Listing
September 2015

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.

N Engl J Med 2015 Aug 21;373(8):714-25. Epub 2015 Jul 21.

From the University of California, San Diego, La Jolla (D.L.W.), Ruane Medical and Liver Health Institute (P.J.R.), the Jeffrey Goodman Clinic, Los Angeles LGBT Center (C.H.), and Southern California Men's Medical Group-Men's Health Foundation (A.M.), Los Angeles, the University of California, San Francisco, San Francisco (A.L.), Veterans Affairs Long Beach Healthcare System, Long Beach (T.R.M.), and Pacific Oaks Medical Group, Beverly Hills (A.S.) - all in California; Johns Hopkins University, Lutherville, MD (M.S.S.); Icahn School of Medicine at Mount Sinai, New York (D.D.); University of Cincinnati College of Medicine, Cincinnati (K.E.S.); Infectious Disease Specialists of Atlanta, Decatur, GA (R.D.); MedStar Washington Hospital Center (D.F.), Whitman-Walker Health (S.H.), and Capital Medical Associates (B.R.) - all in Washington, DC; the Cure C Consortium, Houston (J.C.G.), and Tarrant County Infectious Disease Associates, Fort Worth (C.M.) - both in Texas; Orlando Immunology Center, Orlando (F.H.), and Midway Immunology and Research Center, Fort Pierce (M.R.) - both in Florida; the University of Alabama at Birmingham, Birmingham (E.T.O.); the University of Colorado, Denver (G.R.); Lehigh Valley Health Network, Allentown, PA (J.Y.); and Bristol-Myers Squibb, Wallingford, CT (F.M., P.D.Y., P.A.), and Princeton, NJ (Z.L., E.H., S.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1503153DOI Listing
August 2015

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

N Engl J Med 2015 Aug 21;373(8):705-13. Epub 2015 Jul 21.

From Duke Clinical Research Institute, Durham, NC (S.N.); University of Ottawa, the Ottawa Hospital, Ottawa (C.C.), and Department of Hepatology, Immunodeficiency Clinic, Toronto General Hospital, University of Toronto, Toronto (D.K.W.) - both in Canada; University of Alabama at Birmingham, Birmingham (M. Saag); Emory University, Emory Healthcare, Atlanta (K.W.); Ruane Medical and Liver Health Institute (P.R.) and Kaiser Permanente Los Angeles Medical Center (W.J.T.), Los Angeles, University of California, San Francisco, San Francisco General Hospital, San Francisco (A.L.), and Gilead Sciences, Foster City (L.M.S., J.C.Y., P.G., H.D.-S., L.N., P.S.P., J.G.M.) - all in California; Weill Cornell Medical College (K.M.), Icahn School of Medicine at Mount Sinai (N.B., D.D.), New York, and James J. Peters Veterans Affairs Medical Center, Bronx (N.B.) - all in New York; Beth Israel Deaconess Medical Center (R.P.B.), Brigham and Women's Hospital and Harvard Medical School (P.E.S.), and Community Research Initiative of New England (A.E.C.) - all in Boston; University of Auckland, Auckland City Hospital, Auckland (E.G.), and Christchurch Hospital and University of Otago, Christchurch (C.A.M.S.) - both in New Zealand; University of Puerto Rico School of Medicine (J.S.-B.) and Clinical Research Puerto Rico (J.O.M.-R.) - both in San Juan; University of Miami, Miami (D.J.); University of Pennsylvania, Philadelphia (P.T.); and Johns Hopkins University School of Medicine, Baltimore (M. Sulkowski).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892372PMC
August 2015

Management and diagnosis of fatty liver disease.

Expert Rev Gastroenterol Hepatol 2015 May 26;9(5):671-83. Epub 2015 Feb 26.

Department of Liver Diseases, Icahn School of Medicine at Mount Sinai,1 Gustave Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2015.1003209DOI Listing
May 2015

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

AIDS 2015 Mar;29(5):571-81

aIcahn School of Medicine at Mount Sinai, New York, USA bChelsea and Westminster Hospital, London, UK cHospital Carlos III, Madrid, Spain dEPIMED, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany eHospital de la Santa Creu i Sant Pau, Barcelona, Spain fUniversity of Bonn, Bonn, Germany gRoyal Free Hospital, London, UK hHospital Clínic iHospital Universitari Germans Trias i Pujol and Universitat Autònoma de Barcelona, Barcelona, Spain jMedizinisches Infektiologiezentrum Berlin (MIB), Berlin, Germany kUT Southwestern Medical Center, Dallas, Texas lBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA mBoehringer Ingelheim España S.A., Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000579DOI Listing
March 2015

Is screening baby boomers for HCV enough? A call to screen for hepatitis C virus in persons from countries of high endemicity.

Liver Int 2014 Nov;34(10):1447-51

Centre de Recherche sur l'Inflammation (CRI), INSERM UMR 1149, Université Paris Diderot and Service d'Hépatologie, AP-HP Hôpital Beaujon, Clichy, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12599DOI Listing
November 2014

Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment.

Gastroenterol Hepatol (N Y) 2014 Nov;10(11):706-715

Dr Hearn and Dr Delbello are fellows in the Division of Infectious Diseases; Dr Lawler is a fellow in the Division of Liver Diseases; Mr Ng is a nurse practitioner in the Division of Infectious Diseases and the Division of Liver Diseases; Ms Harty is a nurse in the Division of Liver Diseases; and Dr Dieterich is a professor in the Division of Infectious Diseases and the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai in New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395712PMC
November 2014

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy.

BMC Gastroenterol 2014 Oct 17;14:185. Epub 2014 Oct 17.

Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L, Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-14-185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287486PMC
October 2014

HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.

Curr HIV/AIDS Rep 2014 Sep;11(3):241-9

Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-014-0217-9DOI Listing
September 2014

Pegylated-IFNα2a for HIV/hepatitis C virus coinfected patients: out with the old, in with the new.

Expert Opin Biol Ther 2014 Sep;14(9):1369-78

Icahn School of Medicine , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2014.943180DOI Listing
September 2014

DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.

J Magn Reson Imaging 2014 Jul 4;40(1):90-8. Epub 2013 Nov 4.

Translational and Molecular Imaging Institute and Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.24341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058642PMC
July 2014

Hepatitis C in HIV-infected patients: impact of direct-acting antivirals.

Drugs 2014 Jun;74(9):951-61

Icahn School of Medicine at the Mount Sinai School of Medicine, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-014-0232-6DOI Listing
June 2014

Interferon-free regimens for hepatitis C: combine and conquer.

BioDrugs 2014 Apr;28(2):161-9

Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10129, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40259-013-0072-z
Publisher Site
http://dx.doi.org/10.1007/s40259-013-0072-zDOI Listing
April 2014

HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next?

Clin Infect Dis 2014 Mar 30;58(6):840-7. Epub 2013 Oct 30.

Département de Microbiologie et Infectiologie, Centre Hospitalier de l'Université de Montréal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cit714DOI Listing
March 2014

Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community.

Liver Int 2014 Feb 25;34(2):253-8. Epub 2013 Jul 25.

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12259DOI Listing
February 2014

Hepatitis C direct-acting antiviral agents: changing the paradigm of hepatitis C treatment in HIV-infected patients.

J Clin Gastroenterol 2014 Feb;48(2):106-12

Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000010DOI Listing
February 2014

Treating HCV in HIV 2013: on the cusp of change.

Liver Int 2014 Feb;34 Suppl 1:53-9

Département de Microbiologie et Infectiologie, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12396DOI Listing
February 2014

The pharmacokinetic evaluation of boceprevir for treatment of hepatitis C virus.

Expert Opin Drug Metab Toxicol 2013 Dec 1;9(12):1647-57. Epub 2013 Oct 1.

Icahn School of Medicine at Mount Sinai, Department of Liver Disease , 1468 Madison Ave, Annenberg Building, Room 21-42, New York, NY10029 , USA +1 212 831 8116 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2013.840290DOI Listing
December 2013

Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.

Clin Infect Dis 2013 Dec 30;57(11):1618-25. Epub 2013 Sep 30.

Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cit550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814824PMC
December 2013

Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.

Clin Liver Dis 2013 Nov 4;17(4):657-70, ix. Epub 2013 Sep 4.

Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, Annenberg 21-42, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10893261130003
Publisher Site
http://dx.doi.org/10.1016/j.cld.2013.07.007DOI Listing
November 2013

Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR.

Clin Liver Dis 2013 Feb;17(1):93-103

Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2012.09.001DOI Listing
February 2013

Direct-acting antiviral agents in patients with hepatitis C cirrhosis.

Gastroenterol Hepatol (N Y) 2012 Nov;8(11):727-65

Dr. Im is an Assistant Professor of Medicine in the Division of Liver Diseases, and Dr. Dieterich is a Professor of Medicine in the Division of Liver Diseases, Director of CME in the Department of Medicine, and Director of Outpatient Hepatology, all at Mount Sinai School of Medicine in New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966169PMC
November 2012

A great time to invest in baby Boomer's hepatitis C!

Hepatology 2012 Oct;56(4):1575-7

Division of Infectious Diseases, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25898DOI Listing
October 2012

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.

Clin Infect Dis 2012 Jul 24;55(1):137-44. Epub 2012 Apr 24.

Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cis404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369565PMC
July 2012

Hepatocellular carcinoma in a noncirrhotic patient with HIV: a case report and review of the literature.

Semin Liver Dis 2012 May 3;32(2):186-92. Epub 2012 Jul 3.

Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1316470DOI Listing
May 2012

The end of the beginning for hepatitis C treatment.

Hepatology 2012 Mar;55(3):664-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25528DOI Listing
March 2012

The era of direct-acting antivirals has begun: the beginning of the end for HCV?

Semin Liver Dis 2011 Nov 21;31(4):399-409. Epub 2011 Dec 21.

Research Center in Infectious Diseases, Centre Hospitalier Universitaire de Quebec and Laval University, 2705 Boulevard Laurier, Quebec, Canada.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1297928
Publisher Site
http://dx.doi.org/10.1055/s-0031-1297928DOI Listing
November 2011

The HIV/HCV-coinfected patient and new treatment options.

Clin Liver Dis 2011 Aug;15(3):585-96

Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2011.05.006DOI Listing
August 2011

The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Virchows Arch 2011 Feb 6;458(2):231-5. Epub 2010 Nov 6.

Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-010-1004-7
Publisher Site
http://dx.doi.org/10.1007/s00428-010-1004-7DOI Listing
February 2011

Hepatitis B therapies and antiviral resistance detection and management.

Expert Rev Gastroenterol Hepatol 2009 Dec;3(6):693-9

Department of Medicine, Director of Outpatient Hepatology, Division of Liver Diseases, Mount Sinai School of Medicine, Annenberg 21-42, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/egh.09.64
Publisher Site
http://dx.doi.org/10.1586/egh.09.64DOI Listing
December 2009

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

Clin Gastroenterol Hepatol 2008 Dec 23;6(12):1315-41; quiz 1286. Epub 2008 Aug 23.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California 94304-1509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2008.08.021DOI Listing
December 2008

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

Clin Gastroenterol Hepatol 2008 Dec 23;6(12):1315-41; quiz 1286. Epub 2008 Aug 23.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California 94304-1509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2008.08.021DOI Listing
December 2008

Chronic hepatitis B: preventing, detecting, and managing viral resistance.

Clin Gastroenterol Hepatol 2008 Mar;6(3):268-74

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2007.12.043DOI Listing
March 2008